Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Health-Related Quality of Life in Patients with Relapsed/Refractory Cutaneous T-Cell Lymphoma Treated By Lacutamab: Patient-Reported Outcomes from the Phase 2 Tellomak Trial
Health-Related Quality of Life in Patients with Relapsed/Refractory Cutaneous T-Cell Lymphoma Treated By Lacutamab: Patient-Reported Outcomes from the Phase 2 Tellomak Trial Bagot, M., Kim, Y. H., Ram-Wolff, C., Dalle, S., Mehta-Shah, N., Huen, A., Poligone, B., Zinzani, P., Geskin, L. J., Duval-Modeste, A., Ortiz-Romero, P. L., Sokol, L., Woei-A-Jin, S., Beylot-Barry, M., Dereure, O., Khodadoust, M. S., Battistella, M., Gru, A. A., Moins-Teisserenc, H., Viotti, J., Paiva, C., Chammard, A., Porcu, P. ELSEVIER. 2024: 467-468View details for DOI 10.1182/blood-2024-194796
View details for Web of Science ID 001415654100016